| Literature DB >> 26092398 |
Manuel E Fuentes Salgado1, Bruce Sutor, Robert C Albright, Mark A Frye.
Abstract
Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.Entities:
Year: 2014 PMID: 26092398 PMCID: PMC4477477 DOI: 10.1186/s40345-014-0012-y
Source DB: PubMed Journal: Int J Bipolar Disord ISSN: 2194-7511